Featured Article
Boston Scientific, a global medical technology company, had a strongly positive Q1 2024. Revenue rose 14% to $3.9 billion and earnings before interest and taxes rose 22 % to $674 million over the same period last year. A review of Boston Scientific’s 24 April earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Pricing was not mentioned in their earnings call. Margins were briefly mentioned by…
Read MoreIn This Issue
It is said that Marketing is a luxury, especially in B2B or Industrial Markets. When the economic outlook is poor, many firms…
Read More Earlier this month, we examined compensation packages for revenue generators. In regards to compensation plans in which sales people put 100% of…
Read More There are four basic growth strategies for firms to increase their revenues. These are penetration, geographic, horizontal, and vertical. Each growth strategy…
Read More A necessary process for every new business is attaining sufficient capitalization for developing their product/service, operations, and market. That need for the…
Read More